TRUMF TERUMO CORP
- 17.250
- -1.046-5.72%
TERUMO CORP News
Terumo Corp FY Net Y106.37B Vs Net Y89.33B
Terumo Corp. (4543.TO) Japan Year Ended March 31 GROUP 2024 2023 Revenue Y921.86 bln Y820.21 bln Operating Profit Y140.10 bln Y117.33 bl
TERUMO CORP ADR EACH REPR 1 SHS To Carry Out 2-for-1 Stock Split On April 9th, 2024
March 29th - $TERUMO CORP ADR EACH REPR 1 SHS(TRUMY.US)$ is about to implement a 2-for-1 stock split of shares. The shares will begin trading on a split-adjusted basis from April 9th, 2024.$TERUMO COR
Global Pen Needles Market Report 2024-2034: Regional Analysis by Product, Needle Length, Therapy, and Distribution Channel Featuring Novo Nordisk, Terumo Corp, and Roche Diabetes Care Among Others
Earnings Call Summary | TERUMO CORP(TRUMF.US) Q3 2024 Earnings Conference
The following is a summary of the Terumo Corporation (TRUMF) Q3 2024 Earnings Call Transcript:Financial Performance:Terumo Corporation reported highest ever revenue in Q3 2024 due to double-digit grow
Terumo Says Revenue for Nine Months Ended December 31 Was ¥682.95B
Terumo Corp to Undertake One-to-Two Share Split
Thermometer maker Terumo Corp. (TYO:6418) plans to split its shares and adjust its Articles of Incorporation, as decided by its board of directors on Feb. 7, 2024 to make the trading environment more
TERUMO CORP To Carry Out 2-for-1 Stock Split On March 28th, 2024
February 8th - $TERUMO CORP(TRUMF.US)$ is about to implement a 2-for-1 stock split of shares. The shares will begin trading on a split-adjusted basis from March 28th, 2024.$TERUMO CORP(TRUMF.US)$ rose
Terumo Corp 9-Mos Net Y79.90B Vs Net Y70.18B
Terumo Corp. (4543.TO) Japan Nine Months Ended December 31 GROUP 2023 2022 Revenue Y682.95 bln Y617.99 bln Operating Profit Y105.52 bln
Terumo Corp Sees FY Net Y105.00B
Terumo Corp. also released the following forecasts: GROUP Year Ending Mar 2024 Operating Profit Y140.00 bln Pretax Profit N/A Net Profit Y
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
Needham initiated coverage on Inari Medical Inc (NASDAQ:NARI), noting it as a leader in the very large and underpenetrated market for venous thrombectomy. Inari Medical projects an annual patient popu
Hikaru Samejima to Assume Position as President and CEO of Terumo Corp. in April 2024
Medical thermometer maker Terumo Corp. (TYO:4543) is implementing changes to its executive positions effective April 1, 2024, including the appointment of Hikaru Samejima, as its new president and CEO
Terumo Reports 1H Results
Terumo Corp. Skips Share Buy-Back in October
Terumo Corp. (TYO:4543) skipped share buy-back in October, according to its Wednesday filing. The company said it could buy back up to 5 million shares or 0.67% of its issued shares for up to 20 billi
Terumo GAAP EPS of ¥30.27, Revenue of ¥215.25B
Terumo Corp 1Q Net Y22.55B Vs Net Y22.40B
Terumo Corp. (4543.TO) Japan 1st Quarter Ended June 30 GROUP 2023 2022 Revenue Y215.25 bln Y197.34 bln Operating Profit Y29.64 bln Y30
Terumo GAAP EPS of ¥118.95, Revenue of ¥820.21B
Terumo Corp Sees FY Net Y101.00B
Terumo Corp. also released the following forecasts: GROUP Year Ending Mar 2024 Revenue Y854.00 bln Operating Profit Y132.50 bln Pretax Profit
Terumo Corp FY Net Y89.33B Vs Net Y88.81B
Terumo Corp. (4543.TO) Japan Year Ended March 31 GROUP 2023 2022 Revenue Y820.21 bln Y703.30 bln Operating Profit Y117.33 bln Y115
Terumo GAAP EPS of ¥93.21, Revenue of ¥617.99B
Terumo Corp Sees FY Net Y91.50B
Terumo Corp. also released the following forecasts: GROUP Year Ending Mar 2023 Operating Profit Y122.00 bln Pretax Profit N/A Net Profit
Analysis
Price Target
No Data
